Straumann Price Target, Predictions & Analyst Ratings

-2.57 (-2.45 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume8,162 shs
Average Volume13,145 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Straumann (OTCMKTS:SAUHY) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Based on 9 Analyst Ratings

Analyst Price Target Consensus


High PT$1,745.00
Average PT$1,745.00
Low PT$1,745.00
9/19/20 to 9/19/21
1 Month Ago
8/20/20 to 8/20/21
3 Months Ago
6/21/20 to 6/21/21
1 Year Ago
9/20/19 to 9/19/20
Consensus Rating
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
0 Buy rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$1,745.00$1,745.00N/AN/A
Price Target Upside1,605.27% Upside1,757.77% UpsideN/AN/A
Get Straumann Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SAUHY and its competitors with MarketBeat's FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Straumann (OTCMKTS:SAUHY) vs. Its Competitors

TypeStraumannMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingHoldBuyBuy
Price Target Upside122.66% Upside8.38% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
Community Rating
Outperform Votes
Underperform Votes
Avg. Outperform Votes
Avg. Underperform Votes
Avg. Outperform Votes
Avg. Underperform Votes

Straumann (OTCMKTS:SAUHY) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/20/2021UBS Group
Sebastian Walker
Boost Price TargetNeutral ➝ NeutralCHF 1,230 ➝ CHF 1,745+1,757.77%
8/16/2021JPMorgan Chase & Co.
Reiterated RatingOverweight
8/13/2021Credit Suisse Group
Reiterated RatingOutperform
7/8/2021BNP Paribas
UpgradeNeutral ➝ Outperform
7/8/2021Exane BNP Paribas
Julien Dormois
UpgradeNeutral ➝ Outperform
5/5/2021Berenberg Bank
Reiterated RatingHold
2/8/2021Deutsche Bank Aktiengesellschaft
UpgradeHold ➝ Buy
1/11/2021Stifel Nicolaus
DowngradeBuy ➝ Hold
12/9/2020Morgan Stanley
Reiterated RatingUnderweight
4/17/2020The Goldman Sachs Group
DowngradeNeutral ➝ Sell
1/11/2019Jefferies Financial Group
UpgradeHold ➝ Buy
(Data available from 9/19/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles

Straumann (OTCMKTS:SAUHY) Analyst Ratings Frequently Asked Questions

What is Straumann's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Straumann stock is Hold based on the current 1 sell rating, 3 hold ratings and 5 buy ratings for SAUHY. The average twelve-month price target for Straumann is $1,745.00 with a high price target of $1,745.00 and a low price target of $1,745.00. Learn more on SAUHY's analyst rating history

Do Wall Street analysts like Straumann more than its competitors?

Analysts like Straumann stock less than the stock of other Medical companies. The consensus rating for Straumann is Hold while the average consensus rating for medical companies is Buy. Learn more on how SAUHY compares to other companies

Do MarketBeat users like Straumann more than its competitors?

MarketBeat users like Straumann stock less than the stock of other Medical companies. 58.06% of MarketBeat users gave Straumann an outperform vote while medical companies recieve an average of 67.17% outperform votes by MarketBeat users.

Is Straumann being upgraded by Wall Street analysts?

Over the previous 90 days, Straumann's stock had 2 upgrades by analysts.

Does Straumann's stock price have much upside?

According to analysts, Straumann's stock has a predicted upside of 1,757.77% based on their 12-month price targets.

What analysts cover Straumann?

Straumann has been rated by BNP Paribas, Credit Suisse Group, Exane BNP Paribas, JPMorgan Chase & Co., and UBS Group in the past 90 days.

This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.